Earnings grew 27% to 90 cents per share after a 45% increase ... to chart pattern recognition tools in IBD MarketSurge. The stock then held its gains through several weeks of tight price action.

With the exorbitant cost of insulin practiced in the U.S. in the past decade, more and more private health insurers cannot offer this medication to their clients without charging premium prices for ...